Datasets:
tahasawan
/
Health_Dataset

Dataset card Data Studio Files
xet
 Community
2
Country
stringclasses
20 values
Year
int64
2k
2.02k
Disease Name
stringclasses
20 values
Disease Category
stringclasses
11 values
Prevalence Rate (%)
float64
0.1
20
Incidence Rate (%)
float64
0.1
15
Mortality Rate (%)
float64
0.1
10
Age Group
stringclasses
4 values
Gender
stringclasses
3 values
Population Affected
int64
1k
1,000k
Healthcare Access (%)
float64
50
100
Doctors per 1000
float64
0.5
5
Hospital Beds per 1000
float64
0.5
10
Treatment Type
stringclasses
4 values
Average Treatment Cost (USD)
int64
100
50k
Availability of Vaccines/Treatment
stringclasses
2 values
Recovery Rate (%)
float64
50
99
DALYs
int64
1
5k
Improvement in 5 Years (%)
float64
0
10
Per Capita Income (USD)
int64
502
100k
Education Index
float64
0.4
0.9
Urbanization Rate (%)
float64
20
90
China
2,019
Diabetes
Viral
14.36
1.76
3.81
36-60
Other
19,598
75.71
1.33
2.98
Surgery
15,956
Yes
58.24
2,751
1.77
1,872
0.57
64.71
India
2,011
Asthma
Respiratory
10.99
10.6
6.78
19-35
Female
48,182
72.84
3.92
8.43
Surgery
30,635
Yes
53.72
3,568
7.51
58,653
0.67
42.11
Canada
2,010
Influenza
Viral
14.37
6.51
5.18
0-18
Male
526,371
65.06
4.21
1.25
Medication
49,870
Yes
96.6
2,311
2.53
60,321
0.68
58.67
Australia
2,012
Hepatitis
Neurological
14.65
5.93
5.18
61+
Other
827,146
66.51
0.89
6.17
Vaccination
16,122
Yes
97.76
900
2.84
44,788
0.66
53.93
South Korea
2,020
Dengue
Metabolic
15.58
5.79
9.78
0-18
Other
950,060
66.37
1.71
8.31
Vaccination
21,040
No
51.81
546
0.25
20,689
0.44
20.89
Nigeria
2,015
Rabies
Metabolic
8.56
14.86
2.84
61+
Female
876,200
84.62
3.81
3.13
Therapy
32,221
Yes
80.27
808
0.39
1,622
0.67
32.17
South Korea
2,017
Asthma
Parasitic
5.92
8
2.12
0-18
Male
158,376
91.93
4.17
4.79
Surgery
7,272
Yes
97.14
3,714
7.14
19,983
0.87
35.08
Brazil
2,015
Alzheimer's Disease
Metabolic
5.27
5.56
8.19
36-60
Male
492,249
88.97
0.97
7.18
Therapy
7,665
Yes
70.78
865
8.12
79,355
0.62
46.18
Brazil
2,022
Asthma
Genetic
17.84
4.88
7.57
0-18
Male
256,524
55.41
2.39
5.44
Therapy
21,065
Yes
60.58
4,767
5.97
38,393
0.59
20.95
Germany
2,019
Malaria
Cardiovascular
19.35
12.71
7.71
61+
Other
815,795
93.86
2.18
4.15
Therapy
34,887
Yes
56.22
4,389
1.03
69,665
0.52
40.33
India
2,010
Hepatitis
Parasitic
1.83
4.04
3.52
0-18
Male
652,936
69.86
1.64
2.03
Surgery
34,514
No
93.6
1,235
9.56
18,693
0.9
28.17
Brazil
2,005
Ebola
Cardiovascular
8.23
13.13
3.98
36-60
Female
48,822
52.93
4.86
6.92
Therapy
43,700
Yes
94.45
648
5
46,122
0.43
40.94
Indonesia
2,020
Measles
Neurological
14.62
10.04
0.63
36-60
Male
974,554
80.28
1.99
4.78
Surgery
17,661
No
64.09
1,463
4.99
52,061
0.77
70.91
France
2,007
Alzheimer's Disease
Metabolic
9.94
13.22
0.68
61+
Female
224,970
96.15
1.4
5.24
Therapy
48,343
No
98.29
3,030
5.52
26,007
0.85
47.23
Indonesia
2,008
Polio
Cardiovascular
0.79
0.42
2.47
19-35
Other
268,030
74.55
4.55
6.27
Therapy
4,422
Yes
80.07
2,407
8.05
38,491
0.43
77.9
UK
2,016
Polio
Viral
0.69
2.74
6.19
0-18
Male
836,072
57.61
4.99
7.99
Therapy
2,167
Yes
57.51
3,044
3.87
17,827
0.83
75.95
India
2,013
COVID-19
Chronic
17.97
4.55
8.41
0-18
Male
309,708
89.58
4.38
6.86
Therapy
49,931
No
77.69
4,765
7.73
51,416
0.53
74.13
Indonesia
2,006
Hepatitis
Metabolic
6.2
2.4
6.86
19-35
Female
668,292
54.44
3.53
4.79
Vaccination
43,496
Yes
93.83
1,564
6.67
59,928
0.49
62.02
UK
2,005
Hepatitis
Chronic
2.04
8.94
8.62
36-60
Male
367,230
84.95
3.06
7.52
Vaccination
49,231
No
54.2
4,505
6.81
55,969
0.42
88.15
South Africa
2,015
Parkinson's Disease
Chronic
7.55
13.75
0.54
0-18
Female
331,895
65.74
0.73
3.1
Therapy
38,554
No
91.37
79
3.87
18,025
0.87
40.48
China
2,002
Measles
Metabolic
6.8
10.97
3.38
36-60
Female
371,387
76.49
3.86
9.37
Surgery
12,069
Yes
88.4
749
6.37
95,005
0.52
67.5
Australia
2,018
Polio
Parasitic
6.12
11.3
7.3
36-60
Female
210,995
69.41
1.63
7.78
Vaccination
18,416
No
84.49
4,222
7.85
84,688
0.44
55.67
Germany
2,024
Hepatitis
Chronic
2.6
5.05
1.12
61+
Male
535,278
71.02
4.28
2.56
Surgery
41,309
Yes
95.65
4,320
0.51
23,311
0.58
67.6
Nigeria
2,001
Hypertension
Infectious
19.45
5.5
1.59
36-60
Male
161,287
89.39
4.57
5.46
Therapy
2,749
No
80.56
1,628
9.63
75,193
0.53
61.83
Australia
2,002
Hepatitis
Metabolic
19.83
1.59
8.99
0-18
Other
395,699
92.12
1.76
0.82
Surgery
15,329
Yes
73.87
4,104
2.64
7,986
0.58
29.31
India
2,016
Hypertension
Genetic
10.18
8.98
0.96
61+
Male
930,354
90.86
0.8
5.38
Medication
35,529
Yes
74.47
1,939
8.2
67,593
0.81
20.36
China
2,004
Measles
Viral
15.05
3.06
8.39
0-18
Male
109,498
56.77
2.77
1.03
Therapy
5,047
Yes
98.01
4,928
9.86
3,486
0.71
89.48
South Africa
2,003
Influenza
Viral
11.67
1.25
8.99
19-35
Male
15,723
95.01
0.68
3.69
Medication
41,617
No
60
4,032
9.97
32,909
0.76
58.38
India
2,011
Zika
Infectious
15.02
11.55
8.12
19-35
Other
373,550
76.46
4.93
7.27
Therapy
39,593
Yes
52.92
557
0.82
19,740
0.54
58.1
Indonesia
2,012
COVID-19
Neurological
12.01
10.21
9.43
0-18
Other
834,248
96.83
2.27
3.5
Therapy
34,289
No
72.95
2,210
8.96
926
0.75
67.75
Saudi Arabia
2,000
Hypertension
Cardiovascular
13.03
12.39
5.14
0-18
Female
944,524
90.25
2.44
1.86
Therapy
28,838
No
92.39
1,146
1.91
31,815
0.42
44.14
Japan
2,019
Zika
Chronic
13.41
13.2
9.71
61+
Male
475,185
55.4
0.51
4.59
Vaccination
21,931
No
68.94
3,532
9.65
59,867
0.75
68.72
Russia
2,015
Alzheimer's Disease
Bacterial
12
6.28
1.32
61+
Other
654,696
67.43
1.04
1.08
Medication
22,260
No
67.06
757
7.15
89,107
0.82
88.62
Australia
2,019
Influenza
Bacterial
8.82
8.25
8.69
0-18
Other
286,029
76.3
4.89
7.46
Therapy
25,445
Yes
59.92
1,143
7.75
2,535
0.46
32.96
Australia
2,010
Ebola
Metabolic
5.46
11.88
7.87
0-18
Other
17,321
73.36
2.57
5.16
Therapy
38,067
No
60.58
1,748
7.65
84,508
0.62
20.83
Saudi Arabia
2,010
Diabetes
Genetic
19.47
14.21
5.53
36-60
Male
901,255
70.93
4.8
8.91
Therapy
38,904
No
82.36
3,554
9.26
82,821
0.7
65.47
Argentina
2,007
Malaria
Bacterial
3.73
2.05
5.29
0-18
Male
256,725
57.01
3.37
5.78
Medication
47,887
No
60.05
3,513
6.51
19,235
0.71
46.23
Brazil
2,002
Rabies
Neurological
19.75
10.87
4.9
19-35
Female
824,432
84.07
3.6
7.22
Vaccination
6,190
No
69.14
3,711
3.31
13,062
0.83
77.16
South Korea
2,015
Dengue
Viral
10.13
14.24
7.27
61+
Female
370,763
81.74
0.68
9.95
Surgery
524
Yes
69.89
4,245
4.58
7,901
0.73
41.19
Nigeria
2,015
Asthma
Cardiovascular
12.5
11.41
6.24
0-18
Female
368,445
55.93
2.23
7.74
Medication
322
Yes
82.69
3,759
1.1
65,653
0.88
30.34
UK
2,012
Hepatitis
Bacterial
6.3
12.23
8.42
19-35
Female
733,285
81.65
4.49
3.79
Surgery
1,029
No
77.71
753
6.87
96,115
0.72
78.05
Indonesia
2,018
COVID-19
Viral
16.11
7.71
4.1
36-60
Other
719,785
69.51
3
4.81
Therapy
4,151
No
75.47
2,388
7.7
85,041
0.89
56.58
Nigeria
2,023
Parkinson's Disease
Metabolic
1.95
9.93
1.62
19-35
Male
833,203
74.99
3.25
9.31
Therapy
29,876
No
61.77
3,191
0.01
7,414
0.9
64.01
UK
2,021
Rabies
Infectious
12.08
10.09
1.14
19-35
Female
884,234
94.15
0.95
5
Surgery
13,217
No
80.27
35
5.78
16,905
0.82
77.07
Brazil
2,013
Tuberculosis
Cardiovascular
4.64
13.08
0.72
19-35
Female
152,422
56.02
3.21
9.27
Surgery
23,903
No
51.11
3,433
4.69
83,568
0.59
85.01
Saudi Arabia
2,015
Asthma
Cardiovascular
1.42
6.82
9.23
61+
Female
150,471
68.67
4.32
1.21
Therapy
7,726
Yes
94.91
814
8.1
77,816
0.46
57.07
China
2,002
Malaria
Metabolic
16.56
12.14
5.25
61+
Female
883,797
99.49
4.17
8.42
Therapy
18,533
No
58
4,788
6.86
90,892
0.62
66.74
Indonesia
2,005
Zika
Neurological
4.31
11.47
2.45
0-18
Female
124,615
54.63
0.9
4.35
Therapy
14,553
No
59.93
850
9.31
21,119
0.46
25.47
India
2,013
COVID-19
Autoimmune
16.6
11.5
4.44
36-60
Other
498,954
69.93
2.79
4.89
Vaccination
21,654
Yes
89.74
3,242
6.61
50,363
0.68
76.19
Germany
2,019
COVID-19
Chronic
4.17
5.31
6.46
36-60
Other
855,790
88.37
2.33
9.24
Therapy
24,630
No
80.8
713
6.72
16,047
0.5
39.95
Saudi Arabia
2,005
Ebola
Metabolic
14.5
0.95
6.76
19-35
Female
151,217
84.11
2.84
2.13
Surgery
21,771
No
64.12
1,188
4.96
44,203
0.42
75.21
Indonesia
2,001
HIV/AIDS
Viral
4.29
4.38
1.11
19-35
Female
204,117
93.35
2.61
4.59
Vaccination
25,175
Yes
97.29
3,342
0.89
66,182
0.53
74.95
Indonesia
2,010
Alzheimer's Disease
Neurological
17.15
0.74
5.43
0-18
Male
688,053
85.51
2.62
5.94
Therapy
30,525
No
81.61
2,874
4.16
25,218
0.84
74.83
South Africa
2,002
Diabetes
Infectious
6.07
3.29
8.67
0-18
Female
436,000
77.85
2.84
9.18
Surgery
17,520
Yes
52.62
4,077
3.76
84,806
0.55
80.13
Brazil
2,001
Cholera
Metabolic
3.52
13.88
1.8
61+
Other
546,170
57.17
3.08
9.7
Therapy
1,792
Yes
78.22
1,615
5.23
95,190
0.81
65.42
Argentina
2,019
Tuberculosis
Viral
2.01
4.54
6
19-35
Other
943,263
95.97
2.61
9.12
Therapy
38,328
No
80.35
2,196
3.41
59,135
0.57
56.85
South Africa
2,003
HIV/AIDS
Infectious
16.2
9.21
7.98
0-18
Other
993,467
68.11
4.83
4.43
Therapy
37,478
Yes
97.33
852
9.14
5,178
0.69
43.45
Indonesia
2,016
Parkinson's Disease
Neurological
14.69
13.84
5.87
36-60
Female
29,276
59.36
1.89
3.07
Vaccination
1,774
Yes
87.9
3,530
8.26
52,312
0.89
51
Nigeria
2,015
COVID-19
Parasitic
10.5
2.13
4.33
61+
Male
789,758
85.24
3.02
4.22
Therapy
9,271
Yes
54.51
4,656
6.99
16,414
0.56
40.41
UK
2,024
COVID-19
Respiratory
15.79
5.3
2.95
19-35
Male
734,582
77.02
4.95
0.69
Surgery
35,605
No
67.23
3,498
4.17
1,071
0.44
76.52
South Africa
2,010
HIV/AIDS
Bacterial
15.42
8.5
7.53
19-35
Other
756,717
70.88
0.71
4.47
Surgery
39,752
No
86.29
4,778
8.91
57,412
0.45
83.64
Canada
2,021
Zika
Bacterial
12.96
10.17
9.3
19-35
Male
823,899
70.38
1.98
9.79
Therapy
2,948
Yes
59.57
2,853
0.4
98,346
0.57
79.37
Argentina
2,003
Hepatitis
Bacterial
2.05
4.47
7.45
36-60
Male
682,308
93.84
2.22
9.18
Medication
9,095
Yes
53.56
1,628
9.14
59,588
0.83
81.96
South Korea
2,000
Dengue
Metabolic
4.73
14.28
7.64
36-60
Male
492,393
97.59
3.88
2.58
Medication
47,922
No
95.28
2,128
6.03
78,185
0.62
87.51
Canada
2,022
COVID-19
Neurological
16.8
5.43
5.38
0-18
Female
521,105
76.08
4.54
4.94
Vaccination
7,805
Yes
67.53
2,956
2.4
2,421
0.49
44.3
Argentina
2,004
Parkinson's Disease
Viral
17.4
7.78
0.38
36-60
Other
980,911
71.58
1.54
6.73
Medication
46,039
No
70.84
3,782
1.72
93,113
0.68
64.96
Italy
2,004
HIV/AIDS
Bacterial
6.96
8.41
7.01
36-60
Female
920,507
78.06
2.61
1.83
Surgery
24,390
No
71.38
1,873
7.85
91,576
0.8
53.72
USA
2,020
Polio
Parasitic
18.4
0.35
9.74
61+
Male
206,560
75.96
2.25
6.4
Vaccination
47,340
No
74.75
1,897
0.82
58,788
0.5
50.89
Nigeria
2,024
Cancer
Viral
16.21
2.77
2.93
36-60
Female
867,980
57.94
2.65
9.33
Vaccination
14,395
No
63.28
2,797
7.61
99,905
0.78
81.05
Brazil
2,002
Leprosy
Genetic
9.48
0.26
1.53
19-35
Male
484,527
60.4
1.15
3.92
Vaccination
28,295
No
80.3
1,493
8.53
15,459
0.84
32.6
Mexico
2,007
Asthma
Viral
4.61
2.26
5.6
19-35
Male
37,027
64.57
1.18
7.36
Therapy
32,343
Yes
70.62
3,631
6.87
55,724
0.63
36.54
Japan
2,019
Dengue
Viral
19.36
10.62
9.03
36-60
Male
875,202
65.13
4.61
2.04
Vaccination
49,394
No
92.42
4,931
8.51
7,228
0.62
58.16
Turkey
2,004
Parkinson's Disease
Infectious
5.53
7.08
1.71
0-18
Male
224,423
88.59
1.97
7.86
Surgery
4,875
Yes
91.81
4,289
5.93
86,834
0.82
21.72
Italy
2,017
Measles
Cardiovascular
8.28
1.82
6.26
36-60
Female
223,982
70.89
3.88
4.55
Therapy
48,955
No
83.72
4,311
2.59
45,967
0.47
83.78
USA
2,007
Asthma
Metabolic
13.19
6.81
9.09
0-18
Male
401,363
55.38
3.08
7.17
Therapy
12,044
Yes
88.87
4,756
2.93
48,600
0.75
27.97
India
2,018
Hypertension
Infectious
2.91
13.71
5.16
36-60
Male
624,096
65.07
1.73
9.84
Therapy
36,377
Yes
51.39
1,852
5.1
50,805
0.84
87.45
France
2,011
Cholera
Metabolic
19.11
1.04
6.45
36-60
Female
248,223
92.98
0.69
1.01
Medication
31,599
Yes
60.61
1,698
2.73
14,307
0.81
82.68
China
2,020
Ebola
Viral
2.62
11.51
2.98
19-35
Female
140,732
88.23
2.37
4.1
Vaccination
27,140
Yes
78.36
4,350
5.74
16,271
0.56
25.16
Australia
2,010
Zika
Bacterial
15.22
4.81
1.37
61+
Female
451,151
88.87
2.4
3.04
Medication
11,537
Yes
86.65
2,718
0.51
82,373
0.7
74.92
Saudi Arabia
2,018
Cancer
Genetic
17.25
7.68
1.42
61+
Other
648,244
59.77
4.55
7.05
Therapy
43,174
Yes
71.62
1,526
7.94
76,551
0.55
36.83
South Korea
2,001
Cholera
Genetic
17.05
1.12
1.04
0-18
Male
799,148
96.49
2.16
6.62
Vaccination
19,627
No
60.45
3,206
3.42
13,217
0.75
30.14
UK
2,008
Dengue
Parasitic
16.97
13.04
0.33
61+
Female
404,199
71.86
3.73
6.75
Therapy
22,540
No
54.74
1,202
4.01
82,143
0.74
59.38
South Korea
2,009
Parkinson's Disease
Cardiovascular
5.53
14.64
9.98
19-35
Other
86,098
91.6
3.17
9.08
Therapy
330
No
96.21
2,978
0.52
23,410
0.72
28.37
South Korea
2,007
Influenza
Viral
18.35
9.19
5.51
19-35
Male
837,740
92.39
3.59
3.3
Medication
5,256
No
54.17
3,356
1.24
71,910
0.88
46.24
Turkey
2,000
Alzheimer's Disease
Bacterial
15.58
10.79
9.07
36-60
Other
763,680
56.88
4.58
9.23
Therapy
26,871
No
84.96
2,363
7.8
86,863
0.8
61.14
Canada
2,004
Dengue
Bacterial
11.41
11.83
2.36
36-60
Other
441,598
89.59
3.23
1.15
Therapy
11,184
No
58.75
4,650
3.43
48,688
0.54
41.29
Canada
2,019
Dengue
Cardiovascular
8.62
7.46
2.31
61+
Other
145,837
65.51
2.43
0.71
Surgery
39,647
Yes
60.5
919
7.95
39,674
0.52
29.66
Turkey
2,011
Alzheimer's Disease
Bacterial
1.6
10.64
9.54
61+
Other
580,386
68.71
1.99
7.53
Surgery
41,903
Yes
57.88
2,925
5
70,326
0.88
87.27
India
2,022
Leprosy
Respiratory
9.66
5.31
9.58
61+
Male
406,253
73.04
0.65
8.38
Vaccination
32,393
No
62.07
3,035
9.72
22,547
0.7
72.47
Indonesia
2,006
Rabies
Autoimmune
5.57
9.56
9.86
36-60
Female
563,957
88.32
2.19
1.12
Vaccination
38,438
No
59.72
2,962
0.41
3,868
0.56
29.91
Australia
2,013
Leprosy
Cardiovascular
10.36
3.66
9.95
0-18
Male
722,048
94.23
3.23
8.14
Vaccination
13,441
Yes
79.19
727
3.91
2,760
0.61
53.3
South Africa
2,023
Zika
Cardiovascular
1.52
8.17
7.03
61+
Female
582,088
94.39
1.04
4.3
Vaccination
31,481
No
57.19
4,373
6.06
83,659
0.5
71.72
Mexico
2,016
Hepatitis
Respiratory
5.19
13.83
5.67
36-60
Male
301,969
53.03
3
2.01
Surgery
39,372
Yes
77.88
973
3.67
96,168
0.72
75.37
Italy
2,006
Tuberculosis
Viral
19.45
2.32
5.12
61+
Other
484,776
70.64
2.02
9.99
Medication
21,961
Yes
75.57
1,524
1.1
20,462
0.69
59.8
USA
2,007
COVID-19
Autoimmune
0.71
8.43
8.33
36-60
Female
361,093
94.36
4.06
9.99
Surgery
38,614
Yes
97.64
49
5.42
75,876
0.51
89.7
USA
2,010
Measles
Respiratory
11.75
1.11
4.72
36-60
Other
376,415
95.86
0.91
5.05
Therapy
28,700
Yes
91.99
1,621
9
34,795
0.88
33.16
Saudi Arabia
2,008
Cholera
Parasitic
19.73
5.72
1.67
61+
Female
59,175
62
1.28
8.71
Therapy
6,862
Yes
74.59
210
2.04
57,366
0.76
59.72
China
2,011
COVID-19
Neurological
12.83
9.95
7.04
19-35
Other
827,604
56.31
4.7
3.87
Surgery
42,511
No
89.74
890
9.06
75,179
0.45
82.58
Canada
2,014
Influenza
Chronic
10.42
3.62
5.96
36-60
Other
659,144
89.82
1.38
8.14
Vaccination
38,262
No
97.61
1,752
2.87
98,054
0.78
73.6
USA
2,021
Ebola
Bacterial
0.42
1.58
7.45
36-60
Other
511,296
84.07
2.07
6.42
Therapy
7,716
No
95.79
4,669
0.29
42,880
0.61
73.91